# Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation

> **NCT00604331** · PHASE2 · COMPLETED · sponsor: **Herzzentrum Goettingen** · enrollment: 8 (actual)

## Conditions studied

- Shock, Cardiogenic
- Heart Failure
- Acute Myocardial Infarction

## Interventions

- **DRUG:** Pyruvate

## Key facts

- **NCT ID:** NCT00604331
- **Lead sponsor:** Herzzentrum Goettingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2010-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00604331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00604331, "Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00604331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*